Lupin Limited (LUPIN) Price & Analysis

Compare

12 Followers

LUPIN Stock Chart & Stats

₹1938.85

-₹105.50(-4.47%)

At close: Jan 08 4:00 PM EST

₹1938.85

-₹105.50(-4.47%)

Day’s Range― - ―

52-Week Range₹1,774.00 - ₹2,376.00

Previous CloseN/A

Volume1.35M

Average Volume (3M)25.39K

Market Cap

₹1.05T

Enterprise Value₹1.08T

Total Cash (Recent Filing)₹62.82B

Total Debt (Recent Filing)₹62.17B

Price to Earnings (P/E)20.5

Beta0.62

Next Earnings

May 12, 2026

EPS Estimate

24.77

Next Dividend Ex-DateN/A

Dividend Yield0.57%

Share Statistics

EPS (TTM)33.40

Shares Outstanding457,043,200

10 Day Avg. Volume23,417

30 Day Avg. Volume25,387

Financial Highlights & Ratios

PEG Ratio0.38

Price to Book (P/B)5.20

Price to Sales (P/S)3.94

P/FCF Ratio67.94

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹2,460.00

Price Target Upside26.88% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)110.2

Revenue Forecast (FY)₹271.12B

Bulls Say, Bears Say

Bulls Say

Revenue & Margin TrajectoryLupin has shown durable top-line expansion and strong profitability with a 12.9% revenue rise and high gross (48.9%) and net (14.8%) margins. These metrics indicate sustainable cost controls and pricing power across products, supporting cash generation and reinvestment capacity over months.

Healthy Balance Sheet & ROEA moderate leverage profile (D/E 0.32) combined with a strong equity base and 19.1% ROE signals efficient capital use and financial resilience. This provides flexibility for R&D, M&A or working-capital needs and reduces refinancing risk across a 2-6 month horizon.

Diversified Product & Geographic MixLupin’s business spans generics, branded formulations and specialty products sold across India and regulated markets. This diversification lowers single-market dependency, smooths revenue cycles, and supports durable demand from multiple channels and therapeutic areas over time.

Bears Say

Weak Free Cash Flow ConversionFree cash flow growth sharply lagged (-51.6%) and FCF converts to only 40% of net income, indicating earnings do not fully translate to discretionary cash. This reduces flexibility for dividends, debt paydown or capex and raises dependence on working-capital management to sustain operations.

Exposure To Intense U.S. Generics CompetitionA material portion of revenue comes from U.S. generics where pricing, tender wins and competitor entries drive volume and margins. Structural pricing pressure and fragmented market dynamics can persist, pressuring long-term revenue predictability and margin sustainability.

Revenue Lumpy From Approval & Patent TimingSignificant U.S. sales depend on product launches tied to patent expiries and regulatory approvals. That creates revenue lumpiness and timing risk: delays or failed approvals can materially alter near-term earnings and growth visibility across the next several quarters.

Lupin Limited News

Lupin Receives Two FDA Observations After Ankleshwar Plant Inspection

Lupin Limited ( ($IN:LUPIN) ) has issued an update. Lupin Limited said the U.S. Food and Drug Administration...

12d ago

LUPIN

Lupin Says GST Department Inspection Concludes With No Financial Impact

Lupin Limited ( ($IN:LUPIN) ) has shared an update. Lupin Limited reported that the Maharashtra Goods & Service...

17d ago

LUPIN

Lupin Wins Positive U.S. FDA Inspection Outcome for Goa Plant

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Global drugmaker Lupin Limited has received an Establishment Inspection...

20d ago

LUPIN

Lupin CEO Vinita Gupta Named CNBC Changemaker as U.S. Expansion Gains Momentum

Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited announced that its CEO, Vinita Gupta, has...

21d ago

LUPIN

Lupin Tops Global Pharma and India Rankings in S&P ESG Assessment 2025

Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited has been ranked the number one pharmaceutical...

21d ago

LUPIN

Lupin Partners with TB Alliance to Advance Telacebec for Tuberculosis and Other Mycobacterial Diseases

Lupin Limited ( ($IN:LUPIN) ) has issued an update. Lupin Limited has entered into a strategic collaboration with...

2M ago

LUPIN

Lupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets

The latest announcement is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited has entered into a licensing...

2M ago

LUPIN

Lupin and PolyPeptide Forge Alliance to Boost Global Peptide Supply Chain

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Manufacturing Solutions, a subsidiary of Lupin Limited, has...

3M ago

LUPIN

Lupin Limited Gains U.S. FDA Approval for First Biosimilar, Armlupeg

Lupin Limited ( ($IN:LUPIN) ) has provided an announcement. Lupin Limited announced that it has received approval from...

4M ago

LUPIN

Lupin Limited Faces FDA Inspection Observations at Goa Facility

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Limited announced that the U.S. FDA conducted an...

4M ago

LUPIN

LUPIN FAQ

What was Lupin Limited’s price range in the past 12 months?

Lupin Limited lowest stock price was ₹1774.00 and its highest was ₹2376.00 in the past 12 months.

What is Lupin Limited’s market cap?

Lupin Limited’s market cap is ₹1.05T.

When is Lupin Limited’s upcoming earnings report date?

Lupin Limited’s upcoming earnings report date is May 12, 2026 which is in 54 days.

How were Lupin Limited’s earnings last quarter?

Lupin Limited released its earnings results on Feb 12, 2026. The company reported ₹33.4 earnings per share for the quarter, beating the consensus estimate of ₹27.566 by ₹5.834.

Is Lupin Limited overvalued?

According to Wall Street analysts Lupin Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Lupin Limited pay dividends?

Lupin Limited pays a Annually dividend of ₹12 which represents an annual dividend yield of 0.57%. See more information on Lupin Limited dividends here

What is Lupin Limited’s EPS estimate?

Lupin Limited’s EPS estimate is 24.77.

How many shares outstanding does Lupin Limited have?

Lupin Limited has 457,043,200 shares outstanding.

What happened to Lupin Limited’s price movement after its last earnings report?

Lupin Limited reported an EPS of ₹33.4 in its last earnings report, beating expectations of ₹27.566. Following the earnings report the stock price went up 0.066%.

Which hedge fund is a major shareholder of Lupin Limited?

Currently, no hedge funds are holding shares in IN:LUPIN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Lupin Limited

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Lupin Limited (LUPIN) Earnings & Revenues

Historic Earnings Reports

LUPIN Stock 12 Month Forecast

Average Price Target

₹2,460.00

▲(26.88% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1864":"₹1,864","2461":"₹2,461","2013.25":"₹2,013.3","2162.5":"₹2,162.5","2311.75":"₹2,311.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹2.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹2.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹2.46K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1864,2013.25,2162.5,2311.75,2461],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2311.6,2323.0153846153844,2334.4307692307693,2345.846153846154,2357.2615384615383,2368.6769230769232,2380.0923076923077,2391.507692307692,2402.9230769230767,2414.3384615384616,2425.753846153846,2437.1692307692306,2448.5846153846155,{"y":2460,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2311.6,2323.0153846153844,2334.4307692307693,2345.846153846154,2357.2615384615383,2368.6769230769232,2380.0923076923077,2391.507692307692,2402.9230769230767,2414.3384615384616,2425.753846153846,2437.1692307692306,2448.5846153846155,{"y":2460,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2311.6,2323.0153846153844,2334.4307692307693,2345.846153846154,2357.2615384615383,2368.6769230769232,2380.0923076923077,2391.507692307692,2402.9230769230767,2414.3384615384616,2425.753846153846,2437.1692307692306,2448.5846153846155,{"y":2460,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1894.43,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1944.32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2081.72,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1947.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1949.19,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1865.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1898.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1981.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1964.25,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2086.35,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2103.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2128.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2311.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >